title: [Persistent CK-elevation after CSE inhibitor therapy].
authors.forename: M
authors.initials: M
authors.lastname: Faehling
authors.forename: M
authors.initials: M
authors.lastname: Leschke
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003327:Coronary Disease / Q000139:chemically induced / Q000201:enzymology / Q000517:prevention & control*; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form